DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORy. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) a...
Saved in:
Main Authors | , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
30.08.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORy. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders. |
---|---|
AbstractList | Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORy. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders. |
Author | SINGH, Suresh, B DONG, Chengguo DILLARD, Lawrence, Wayne TICE, Colin, M CLAREMON, David, A ZHAO, Wei FAN, Yi JIA, Lanqi MARCUS, Andrew ZHUANG, Linghang ZHENG, Yajun LOTESTA, Stephen, D YUAN, Jing |
Author_xml | – fullname: CLAREMON, David, A – fullname: ZHUANG, Linghang – fullname: LOTESTA, Stephen, D – fullname: DILLARD, Lawrence, Wayne – fullname: ZHAO, Wei – fullname: FAN, Yi – fullname: SINGH, Suresh, B – fullname: ZHENG, Yajun – fullname: DONG, Chengguo – fullname: TICE, Colin, M – fullname: MARCUS, Andrew – fullname: JIA, Lanqi – fullname: YUAN, Jing |
BookMark | eNrjYmDJy89L5WTQc_H0iHQJ8g-IDAry9wFRni6efq4Knn4enk6eIf5BwQr-bgpB_kG67o6-vo48DKxpiTnFqbxQmptBxc01xNlDN7UgPz61uCAxOTUvtSQ-wMPQyMDQ3NTAwNTC2NHQmEhlAAD0KSo |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | PH12017500583A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_PH12017500583A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:25:10 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_PH12017500583A13 |
Notes | Application Number: PH20171500583 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170830&DB=EPODOC&CC=PH&NR=12017500583A1 |
ParticipantIDs | epo_espacenet_PH12017500583A1 |
PublicationCentury | 2000 |
PublicationDate | 20170830 |
PublicationDateYYYYMMDD | 2017-08-30 |
PublicationDate_xml | – month: 08 year: 2017 text: 20170830 day: 30 |
PublicationDecade | 2010 |
PublicationYear | 2017 |
RelatedCompanies | VITAE PHARMACEUTICALS, INC |
RelatedCompanies_xml | – name: VITAE PHARMACEUTICALS, INC |
Score | 3.103242 |
Snippet | Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170830&DB=EPODOC&locale=&CC=PH&NR=12017500583A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR3LTsMwzJoGAm4wQAwY6mHqrbD1sWyHCm1NS4toU4WCttO0dKnEgW5iRfw-SdTxuMApD0tOYsnxI7EN0C0WBZN5tw1WmMywuekYI3vIDZ4jvlyOLHuoXBdxMgif7PupM23A6zYWRuUJ_VDJEQVH5YLfK3Vfr7-dWFj9rdzcsBcxtboNMhfrtXXcR0Kj6Ol44vopwcTTPc9NQz2hbl8CHVlEzxoLY2lHaNJIMoT_PJGBKeufUiU4hN1UICyrI2jwsgX73rb4Wgv24vrNW3Rr9tscwzWOwhmmJJ1RSh5kE-Eo8bUoCaNJlBH6qJFAo4Qad-M4Hp9AN_AzLzTEwvOvg87T8Nc2rVNolquSn4HGkcn4wEQLi-V2bi8Xgr5CMUMy1Qsb5UUbOn-iOv8HfgEHcqicpb1LaFZv77wjpG3FrhSNPgFv2H3G |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dT8IwEL8QNOKbokZUdA9kb1PYBoOHxcC62SpblzkNPBE6usQHB5EZ_33bBvx40ac2veTaXvLrXa-9O4BWPs-ZzLttsNxkhs3NrjGw-9zgmcMXi4Fl95XrIox6-Mm-n3QnFXjdxsKoPKEfKjmiQFQm8F6q83r17cRC6m_l-oa9iKHlbZC6SN_cjjuOsCjaOhq5fkwR9XTPc2OsR4nbkcSuLKJnDcVlaUdY2Y4EhP88koEpq59aJTiA3VgwLMpDqPCiDjVvW3ytDnvh5s1bdDfwWx_BNSJ4ihIaT5OEjmVDEIl8jUSYjEhKk0eNBlpCE-NuGIbDY2gFfuphQ0w8-9roLMa_lmmdQLVYFvwUNO6YjPdMZ26xzM7sxVzIVxhmjkz1wgZZ3oDmn6zO_qFfQQ2n4Xg2JtHDOexLknKcti-gWr6986bQvCW7VPL6BIEQgLk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DIHYDROPYRROLOPYRIDINE+INHIBITORS+OF+ROR-GAMMA&rft.inventor=CLAREMON%2C+David%2C+A&rft.inventor=ZHUANG%2C+Linghang&rft.inventor=LOTESTA%2C+Stephen%2C+D&rft.inventor=DILLARD%2C+Lawrence%2C+Wayne&rft.inventor=ZHAO%2C+Wei&rft.inventor=FAN%2C+Yi&rft.inventor=SINGH%2C+Suresh%2C+B&rft.inventor=ZHENG%2C+Yajun&rft.inventor=DONG%2C+Chengguo&rft.inventor=TICE%2C+Colin%2C+M&rft.inventor=MARCUS%2C+Andrew&rft.inventor=JIA%2C+Lanqi&rft.inventor=YUAN%2C+Jing&rft.date=2017-08-30&rft.externalDBID=A1&rft.externalDocID=PH12017500583A1 |